|1.||Li, Xiaotao: 2 articles (11/2010 - 06/2007)|
|2.||Delia, Domenico: 2 articles (08/2009 - 02/2008)|
|3.||Zannini, Laura: 2 articles (08/2009 - 02/2008)|
|4.||Buscemi, Giacomo: 2 articles (08/2009 - 02/2008)|
|5.||Lisanti, Sofia: 2 articles (08/2009 - 02/2008)|
|6.||Fontanella, Enrico: 2 articles (08/2009 - 02/2008)|
|7.||Monaco, John J: 2 articles (06/2007 - 03/2004)|
|8.||Moriya, Kyoji: 2 articles (02/2007 - 01/2007)|
|9.||Koike, Kazuhiko: 2 articles (02/2007 - 01/2007)|
|10.||Tanaka, Keiji: 2 articles (02/2007 - 01/2007)|
03/19/2008 - "Manipulation of the level of PA28gamma, an approach that would regulate the cellular content of p53, may improve the efficacy of current cancer therapies."
01/01/2009 - "In present study, we found oncogenicity of MDA-MB-231 cell transfected with REGgamma was enhanced, which might be realized via REGgamma promoting cell growth, inhibiting cell apoptosis, degrading P21 and suppressing activation of NK, suggesting REGgamma promoting tumor growth is a process involving multiple factor mechanisms."
12/01/2008 - "The discovery that REGgamma regulates cell-cycle regulators is consistent with previous studies where REGgamma-deficient mice have shown retardation in body growth, decreased cell proliferation and increased apoptosis, indicating a potential role of REGgamma in cancer development. "
03/01/2014 - "The overexpression of REGgamma enhanced cancer cell proliferations (P < 0.05), promoted more cells into the S+G2/M phase (P < 0.05) and promoted the migration of cancer cells (P < 0.05). "
01/21/2014 - "All these findings strongly imply that the overexpression of PA28gamma resulted from miR-7 downexpression in NSCLC has an important role in promoting cancer cell progress and consequently results in NSCLC growth. "
02/01/2007 - "In this study, we examined whether PA28gamma is required for HCV core-induced insulin resistance in vivo. "
02/01/2007 - "We have previously reported that HCV core gene-transgenic (PA28gamma(+/+)CoreTg) mice develop marked insulin resistance and that the HCV core protein is degraded in the nucleus through a PA28gamma-dependent pathway. "
|3.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/01/1989 - "An enzyme-linked immunosorbent assay using the purified Ki antigen was established, and the clinical significance of the anti-Ki antibody in systemic lupus erythematosus (SLE) was studied. "
12/01/1989 - "Purification and characterization of Ki antigen and detection of anti-Ki antibody by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus."
02/01/1990 - "Patients with systemic lupus erythematosus (SLE) produce autoantibodies against a variety of nuclear antigens including Ki antigen. "
02/01/1990 - "Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus."
|5.||Chromosomal Instability (Chromosome Stability)
|1.||Proteasome Endopeptidase Complex (Proteasome)
|2.||Nuclear Antigens (Extractable Nuclear Antigens)
|3.||Complementary DNA (cDNA)
|5.||Messenger RNA (mRNA)
|6.||Nuclear Proteins (Protein, Nuclear)
|1.||Transplantation (Transplant Recipients)